Works matching IS 09697128 AND DT 2009 AND VI 16 AND IP 12

Results: 9

A modified E2F-1 promoter improves the efficacy to toxicity ratio of oncolytic adenoviruses.

Published in:

Gene Therapy, 2009, v. 16, n. 12, p. 1441, doi. 10.1038/gt.2009.103

By:

Rojas, J. J.;
Cascallo, M.;
Guedan, S.;
Gros, A.;
Martinez-Quintanilla, J.;
Hemminki, A.;
Alemany, R.

Publication type:

Article

Highly efficient eradication of intracranial glioblastoma using Eg5 siRNA combined with HVJ envelope.

Published in:

Gene Therapy, 2009, v. 16, n. 12, p. 1465, doi. 10.1038/gt.2009.99

By:

Matsuda, M.;
Yamamoto, T.;
Matsumura, A.;
Kaneda, Y.

Publication type:

Article

Naturally occurring singleton residues in AAV capsid impact vector performance and illustrate structural constraints.

Published in:

Gene Therapy, 2009, v. 16, n. 12, p. 1416, doi. 10.1038/gt.2009.101

By:

Vandenberghe, L. H.;
Breous, E.;
Nam, H-J.;
Gao, G.;
Xiao, R.;
Sandhu, A.;
Johnston, J.;
Debyser, Z.;
Agbandje-McKenna, M.;
Wilson, J. M.

Publication type:

Article

A versatile nonviral vector system for tetracycline-dependent one-step conditional induction of transgene expression.

Published in:

Gene Therapy, 2009, v. 16, n. 12, p. 1383, doi. 10.1038/gt.2009.105

By:

Inoue, K.;
Sone, T.;
Oneyama, C.;
Nishiumi, F.;
Kishine, H.;
Sasaki, Y.;
Andoh, T.;
Okada, M.;
Chesnut, J. D.;
Imamoto, F.

Publication type:

Article

Efficient delivery of angiostatin K1-5 into tumors following insertion of an NGR peptide into adenovirus capsid.

Published in:

Gene Therapy, 2009, v. 16, n. 12, p. 1405, doi. 10.1038/gt.2009.97

By:

Jullienne, B.;
Vigant, F.;
Muth, E.;
Chaligné, R.;
Bouquet, C.;
Giraudier, S.;
Perricaudet, M.;
Benihoud, K.

Publication type:

Article

Fatty acid–spermine conjugates as DNA carriers for nonviral in vivo gene delivery.

Published in:

Gene Therapy, 2009, v. 16, n. 12, p. 1429, doi. 10.1038/gt.2009.108

By:

Viola, J. R.;
Leijonmarck, H.;
Simonson, O. E.;
Oprea, I. I.;
Frithiof, R.;
Purhonen, P.;
Moreno, P. M. D.;
Lundin, K. E.;
Strömberg, R.;
Smith, C. I. E.

Publication type:

Article

Analysis of genetically engineered oncolytic herpes simplex viruses in human prostate cancer organotypic cultures.

Published in:

Gene Therapy, 2009, v. 16, n. 12, p. 1477, doi. 10.1038/gt.2009.94

By:

Passer, B. J.;
Wu, C-l.;
Wu, S.;
Rabkin, S. D.;
Martuza, R. L.

Publication type:

Article

Systemic administration of a PEGylated adenovirus vector with a cancer-specific promoter is effective in a mouse model of metastasis.

Published in:

Gene Therapy, 2009, v. 16, n. 12, p. 1395, doi. 10.1038/gt.2009.95

By:

Yao, X.;
Yoshioka, Y.;
Morishige, T.;
Eto, Y.;
Watanabe, H.;
Okada, Y.;
Mizuguchi, H.;
Mukai, Y.;
Okada, N.;
Nakagawa, S.

Publication type:

Article

Retroviral vector integration in post-transplant hematopoiesis in mice conditioned with either submyeloablative or ablative irradiation.

Published in:

Gene Therapy, 2009, v. 16, n. 12, p. 1452, doi. 10.1038/gt.2009.96

By:

Sadat, M. A.;
Dirscherl, S.;
Sastry, L.;
Dantzer, J.;
Pech, N.;
Griffin, S.;
Hawkins, T.;
Zhao, Y.;
Barese, C. N.;
Cross, S.;
Orazi, A.;
An, C.;
Goebel, W. S.;
Yoder, M. C.;
Li, X.;
Grez, M.;
Cornetta, K.;
Mooney, S. D.;
Dinauer, M. C.

Publication type:

Article